Page last updated: 2024-10-26

diethylcarbamazine and Stevens-Johnson Syndrome

diethylcarbamazine has been researched along with Stevens-Johnson Syndrome in 1 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, WH1
Hung, SI1
Hong, HS1
Hsih, MS1
Yang, LC1
Ho, HC1
Wu, JY1
Chen, YT1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency[NCT01379469]Phase 220 participants (Actual)Interventional2012-01-31Terminated
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for diethylcarbamazine and Stevens-Johnson Syndrome

ArticleYear
Medical genetics: a marker for Stevens-Johnson syndrome.
    Nature, 2004, Apr-01, Volume: 428, Issue:6982

    Topics: Alleles; Asian People; China; Diethylcarbamazine; HLA-B Antigens; HLA-B15 Antigen; Humans; Incidence

2004